NorthMiRs Inc., an innovative cardiovascular biotech start-up, has won $250,000 in funding from the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) PITCH 2024 competition. Since its launch in 2018, the ECHO...
Congenital heart disease (CHD) is the most commonly occurring birth anomaly. Despite a strong genetic basis, almost 90% of cases remain genetically undiagnosed. However, the surge of new technology is enabling a search for hidden gene defects not detectable on...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
3D models of heart failure… stiffened hearts in diabetes…. saving infant lives
After a heart attack, this peptide protects the heart from further injury
Featured Event
ECHO PITCH 2024
Virtual Library
Visit our YouTube channel filled with world-class heart failure educational sessions on diverse topics
ECHO Webinar: Elena Di Martino, ViTAA Medical Solutions
January 25, 2022 @ 11:00 am - 12:00 pm EST
Please join us for an ECHO webinar on Tuesday Jan 25, 2022 (11 am – 12 pm EST) featuring Dr. Elena Di Martino (Co-Founder & Chief Scientific Officer, ViTAA Medical Solutions; Professor, Biomedical Engineering, University of Calgary).
Dr. Di Martino’s presentation entitled, “A new paradigm for the assessment of aortic aneurysms”, will feature an overview of ViTAA Medical Solutions, its technologies and the story behind its success.
ViTAA Medical Solutions is a digital health company headquartered in Montreal, that is focused on employing software to aid physicians in personalizing the care of patients with aortic aneurysms. ViTAA’s technology has been developed and refined over the last decade by the team led by Prof. Elena Di Martino at the University of Calgary in collaboration with vascular surgeon Dr. Randy Moore.